Amphenol (NYSE: APH) reported Q1 EPS of $0.71, $0.03 worse than the analyst estimate of $0.74. Revenue for the quarter came in at $1.86 billion versus the consensus estimate of $1.84 billion.

• “As we look ahead, the overall demand and operating environment remains highly uncertain. The full impact of the COVID-19 pandemic on our business will depend on many unpredictable future developments, including the length and severity of the crisis, potential additional government actions and the overall impact of the pandemic on the global economy, among many other factors. As a result, until conditions become more predictable, we believe it is prudent to withdraw our full-year sales and EPS guidance, and we will not be providing a specific outlook for the coming quarter. Given these dynamics, however, we expect sales and EPS in the second quarter of 2020 to be lower than the levels we achieved in the first quarter.”

For earnings history and earnings-related data on Amphenol (APH) click here.